Saturday, November 23, 2024
HomeTagsEuropean Medicines

European Medicines

European Medicines Agency Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec for People with Hemophilia B

Global biotherapeutics leader CSL Behring today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for etranacogene dezaparvovec (EtranaDez)...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics